Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Peringkat dalam Saham #26080
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Harga Saham
$0.72978769
Kapitalisasi Pasar
$43.65M
Perubahan (1 hari)
1.10%
Perubahan (1 tahun)
-17.81%
Negara
TW
Perdagangan Bioptik Technology Incorporation (4161)

Kategori

Riwayat hasil dividen untuk Bioptik Technology Incorporation (4161)
Hasil dividen (TTM) dari Bioptik Technology Incorporation (simbol saham: 4161) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Bioptik Technology Incorporation (4161) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing